News
PNC Financial Secures Regulatory Nod for $4.1B FirstBank Acquisition
The PNC Financial Services Group, Inc. PNC has secured the regulatory approvals needed to complete its previously announced $4.1 billion cash-and-stock acquisition of FirstBank Holding Company
UiPath Soars 51% in Three Months: Accumulate Now or Wait for a Pause?
UiPath Inc. PATH stock has skyrocketed 51% in the past three months, while gaining 29% in the past month, indicating that market sentiment has shifted meaningfully in the company’s favor.
3 Reasons Growth Investors Will Love Core & Main (CNM)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Here is Why Growth Investors Should Buy Orla Mining (ORLA) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
3 Reasons Growth Investors Will Love Daktronics (DAKT)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
3 HMO Stocks in Focus Despite Rising Medical Costs, Regulatory Pressures
Financial Sector Breaks Out as Capital Rotates and Leadership Shifts
With market headlines dominated last week by the Fed’s rate cut decision, renewed concerns around AI capex returns, highlighted by Oracle's (NYSE:ORCL) sharp selloff, and signs of a weakening
Surging Earnings Estimates Signal Upside for Synopsys (SNPS) Stock
Synopsys (SNPS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its
Will Lamb Weston (LW) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Lamb Weston (LW), which belongs to the Zacks
Vince Holding Corp. (VNCE) Is Up 17.57% in One Week: What You Should Know
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Bank7 (BSVN) Upgraded to Buy: Here's Why
Bank7 (BSVN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward
ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on Progyny (PGNY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of
Millicom International Cellular SA (TIGO) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Northrim BanCorp (NRIM) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Investors might want to bet on Intensity Therapeutics Inc. (INTS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates
O-I Glass (OI) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
What Makes Prenetics Global Limited (PRE) a Strong Momentum Stock: Buy Now?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
Werewolf Therapeutics, Inc. (HOWL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings
All You Need to Know About Alto Ingredients (ALTO) Rating Upgrade to Strong Buy
Alto Ingredients (ALTO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings
Bread Financial Holdings (BFH) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Nuvation Bio (NUVB) Upgraded to Buy: Here's What You Should Know
Nuvation Bio Inc. (NUVB) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of